{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:01:00Z","timestamp":1776898860613,"version":"3.51.2"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jaad.2022.08.052","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T22:17:04Z","timestamp":1662416224000},"page":"1287-1294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis"],"prefix":"10.1016","volume":"87","author":[{"given":"Xiaoting","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanliang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonghui","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijie","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bixia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey E.","family":"Gershenwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles M.","family":"Balch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2022.08.052_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cll.2011.03.005","article-title":"Acral lentiginous melanoma","volume":"31","author":"Piliang","year":"2011","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.jaad.2022.08.052_bib2","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1245\/s10434-020-08418-5","article-title":"The clinicopathological and survival profiles comparison across primary sites in acral melanoma","volume":"27","author":"Wei","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jaad.2022.08.052_bib3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jdermsci.2019.04.003","article-title":"Classification of 3097 patients from the Japanese melanoma study database using the American Joint Committee on Cancer eighth edition cancer staging system","volume":"94","author":"Fujisawa","year":"2019","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2022.08.052_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4068\/cmj.2016.52.3.185","article-title":"Cutaneous melanoma in Asians","volume":"52","author":"Kim","year":"2016","journal-title":"Chonnam Med J"},{"key":"10.1016\/j.jaad.2022.08.052_bib5","first-page":"115","article-title":"Acral lentiginous melanoma presents distinct clinical profile with high cancer susceptibility","volume":"20","author":"Nagore","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jaad.2022.08.052_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2022.08.052_bib7","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jaad.2019.01.081","article-title":"Early detection of acral melanoma: a review of clinical, dermoscopic, histopathologic, and molecular characteristics","volume":"81","author":"Darmawan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2022.08.052_bib8","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/cam4.2110","article-title":"Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma","volume":"8","author":"Fujisawa","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.jaad.2022.08.052_bib9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archdermatol.2008.609","article-title":"Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005","volume":"145","author":"Bradford","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2022.08.052_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2133.2000.03651.x","article-title":"Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients","volume":"143","author":"Kuchelmeister","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2022.08.052_bib11","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jaad.2022.08.052_bib12","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.jaad.2022.08.052_bib13","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2022.08.052_bib14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jso.25343","article-title":"Clinical implications of the eighth edition of the American Joint Committee on Cancer melanoma staging","volume":"119","author":"Crompton","year":"2019","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jaad.2022.08.052_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/bjd.15803","article-title":"Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients","volume":"178","author":"Teramoto","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2022.08.052_bib16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/jdv.13913","article-title":"Survival of acral lentiginous melanoma in the National Cancer Institute of Colombia","volume":"31","author":"Duarte","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2022.08.052_bib17","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/bjd.21026","article-title":"Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study","volume":"186","author":"Wei","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2022.08.052_bib18","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/1097-0142(19950515)75:10<2499::AID-CNCR2820751016>3.0.CO;2-8","article-title":"Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification","volume":"75","author":"Buttner","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2022.08.052_bib19","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2022.08.052_bib20","author":"Cassell"},{"key":"10.1016\/j.jaad.2022.08.052_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/10732748211053567","article-title":"Acral lentiginous melanoma: a United States multi-center substage survival analysis","volume":"28","author":"Kolla","year":"2021","journal-title":"Cancer Control"},{"key":"10.1016\/j.jaad.2022.08.052_bib22","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1200\/JCO.20.02110","article-title":"Longer follow-up confirms recurrence-free survival benefit of adjuvant pembrolizumab in high-risk stage III melanoma: updated results from the EORTC 1325-MG\/KEYNOTE-054 trial","volume":"38","author":"Eggermont","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2022.08.052_bib23","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa2005493","article-title":"Five-year analysis of adjuvant dabrafenib plus trametinib in stage III melanoma","volume":"383","author":"Dummer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2022.08.052_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2217\/fon-2017-0500","article-title":"Evaluation of the eighth American Joint Committee on Cancer staging system for malignant melanoma of the skin","volume":"14","author":"Abdel-Rahman","year":"2018","journal-title":"Future Oncol"},{"key":"10.1016\/j.jaad.2022.08.052_bib25","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.2217\/fon-2019-0666","article-title":"KEYNOTE-716: phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma","volume":"16","author":"Luke","year":"2020","journal-title":"Future Oncol"},{"key":"10.1016\/j.jaad.2022.08.052_bib26","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/cncr.32585","article-title":"Considering adjuvant therapy for stage II melanoma","volume":"126","author":"Poklepovic","year":"2020","journal-title":"Cancer"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222026275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222026275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:03:31Z","timestamp":1759273411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962222026275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0190962222026275"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2022.08.052","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2022.08.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}